Patents by Inventor Gi-Jin Kim

Gi-Jin Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11524036
    Abstract: Provided is a composition including mesenchymal stem cells as an effective ingredient for prevention, alleviation, or treatment of thyroid-associated ophthalmopathy. A pharmaceutical composition including mesenchymal stem cells as an effective ingredient for treatment of thyroid-associated ophthalmopathy allows patients with thyroid-associated ophthalmopathy to recover from an abnormal increase in hyaluronic acid production in orbital fibroblasts, increased adipocyte differentiation, and increased lipid accumulation, and thus may be useful for the treatment of thyroid-associated ophthalmopathy.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: December 13, 2022
    Assignee: SUNGKWANG MEDICAL FOUNDATION
    Inventors: He Len Lew, Mi Ra Park, Gi Jin Kim
  • Publication number: 20220010280
    Abstract: Provided is a composition for inhibiting, preventing, alleviating, or treating adipogenesis. Mesenchymal stem cells according to one aspect or a composition comprising the same inhibit fat accumulation or adipose tissue increase and thus may be advantageously utilized in the prevention, treatment, or alleviation of diseases associated with abnormal fat metabolism.
    Type: Application
    Filed: November 22, 2019
    Publication date: January 13, 2022
    Applicants: CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, SUNGKWANG MEDICAL FOUNDATION
    Inventors: Gi Jin KIM, Jae Yeon KIM, He Len LEW
  • Publication number: 20200246392
    Abstract: Provided is a composition including mesenchymal stem cells as an effective ingredient for prevention, alleviation, or treatment of thyroid-associated ophthalmopathy. A pharmaceutical composition including mesenchymal stem cells as an effective ingredient for treatment of thyroid-associated ophthalmopathy allows patients with thyroid-associated ophthalmopathy to recover from an abnormal increase in hyaluronic acid production in orbital fibroblasts, increased adipocyte differentiation, and increased lipid accumulation, and thus may be useful for the treatment of thyroid-associated ophthalmopathy.
    Type: Application
    Filed: August 16, 2018
    Publication date: August 6, 2020
    Applicant: SUNGKWANG MEDICAL FOUNDATION
    Inventors: He Len LEW, Mi Ra PARK, Gi Jin KIM
  • Publication number: 20180296608
    Abstract: The present invention can improve or recover ovarian functions of mammals by containing spheroidal cell aggregates including placenta-derived mesenchymal stem cells as an active ingredient.
    Type: Application
    Filed: September 27, 2016
    Publication date: October 18, 2018
    Inventors: Tae-Hee KIM, SangHoon LEE, Gi Jin KIM, Ji Young HWANG, Jong Ho CHOI, Yesl JUN
  • Publication number: 20100112697
    Abstract: The present invention provides a method for isolating mesenchymal stem cells derived from a placental chorionic plate membrane, the method including: (a) harvesting a chorionic plate membrane from a detached placenta; (b) harvesting cells present in the chorionic plate membrane obtained in step (a) by scraping; (c) adding a solution containing trypsin and ethylenediaminetetraacetate to the cells obtained in step (b) to perform an enzymatic reaction and adding a fetal bovine serum thereto to terminate the enzymatic reaction; and (d) centrifuging the reaction solution obtained in step (c) and culturing the obtained cells in a medium containing a fetal bovine serum and an antibiotic.
    Type: Application
    Filed: October 24, 2007
    Publication date: May 6, 2010
    Applicants: CHABIO & DIOSTECH CO., LTD., COLLEGE OF MEDICINE POCHON CHA UNIVERSITY INDUSTRY
    Inventors: Gi-Jin Kim, Kyung-Sun Shin, Kyu-Hwan Na, Hyung-Min Chung